Cost-Effectiveness of Preventing Acute-Phase HIV Transmission
预防艾滋病毒急性期传播的成本效益
基本信息
- 批准号:7544905
- 负责人:
- 金额:$ 31.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-01-25 至 2010-12-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS preventionAcuteAddressAnti-Retroviral AgentsAntibodiesBehavioralCosts and BenefitsCounselingCoupledDevelopmentEconomicsEpidemicEpidemiologyExposure toHIVHIV InfectionsIncidenceInfectionInfection preventionInterventionKnowledgeMorbidity - disease rateNIH Program AnnouncementsParticipantPatientsPersonsPhasePlayPoliciesPopulationPrevalencePreventionPrevention strategyPreventive InterventionProceduresProphylactic treatmentProtocols documentationPublishingRNARelative (related person)RiskRisk ReductionRoleSamplingServicesSpecificitySpecimenTestingUnited States National Institutes of HealthViruscostcost effectivenesseconomic costeconomic impactindexingmathematical modelmortalitynovelpreventprevention serviceprogramstherapy developmenttransmission process
项目摘要
DESCRIPTION (provided by applicant): Novel intervention strategies are needed to reduce HIV incidence in the US below the current 40K plateau. The highly-infectious acute phase of initial infection represents a promising but relatively unexplored target for behavioral change interventions. Interventions that identify acutely-infected persons and help them reduce their risk of transmitting the virus to others could play an important role in efforts to reduce HIV incidence below the 40K plateau. However, the ultimate impact of these interventions depends on the actual extent of transmission during the acute phase of infection, as well as on the cost-effectiveness of potential interventions to reduce acute-phase HIV transmission. To enhance current understanding of the epidemiological impact of acute-phase HIV transmission and the cost-effectiveness of potential strategies to reduce HIV transmission during this period of elevated infectiousness, we will: 1) Develop mathematical models and procedures to estimate the annual number of incident HIV infections due to acute-phase transmission, the total number of such infections from 1998 through 2004, and the potential epidemiological and economic impact of interventions to reduce acute-phase HIV transmission. 2) Assess the efficiency and cost-effectiveness of supplementing existing HIV counseling and testing services with HIV-RNA testing of pooled test samples to facilitate identification of acutely-infected persons and encourage behavioral risk reduction to prevent acute-phase HIV transmission. 3) Assess the costs and estimate the number of HIV infections averted by a comprehensive post-exposure prophylaxis program that combined antiretroviral prophylaxis with either a 2-session behavioral risk reduction intervention or a more intensive 5-session intervention. This project will provide estimates of the magnitude and consequences of acute-phase HIV transmission, and the potential economic efficiency of various intervention strategies to prevent transmission during the acute phase of infection. This information is needed by decision makers at federal, state, and local levels who must prioritize HIV prevention intervention development and implementation. The results will inform scientific and policy discussions on the importance of interventions to reduce acute-phase transmission.
描述(由申请人提供):需要新的干预策略来降低美国的艾滋病毒发病率,使其低于目前的40 K平台。初始感染的高传染性急性期是行为改变干预的一个有希望但相对未探索的目标。识别急性感染者并帮助他们降低将病毒传染给他人的风险的干预措施,可以在将艾滋病毒发病率降低到40 K高原以下的努力中发挥重要作用。然而,这些干预措施的最终影响取决于感染急性期的实际传播程度,以及减少艾滋病毒急性期传播的潜在干预措施的成本效益。为了加强目前对急性期艾滋病毒传播的流行病学影响以及在这一传染性升高时期减少艾滋病毒传播的潜在战略的成本效益的理解,我们将:1)开发数学模型和程序,以估计每年因急性期传播而感染艾滋病毒的人数,1998年至2004年这类感染的总数,以及为减少急性期艾滋病毒传播而采取的干预措施的潜在流行病学和经济影响。2)评估以混合测试样本的HIV-RNA测试补充现有艾滋病毒咨询和测试服务的效率和成本效益,以促进识别急性感染者,并鼓励减少行为风险,以预防急性期艾滋病毒传播。3)评估成本,并估计通过全面的暴露后预防计划避免的艾滋病毒感染人数,该计划将抗逆转录病毒预防与2次行为风险降低干预或更密集的5次干预相结合。该项目将提供对急性期艾滋病毒传播的规模和后果的估计,以及在感染急性期预防传播的各种干预战略的潜在经济效益。这些信息是联邦、州和地方各级决策者所需要的,他们必须优先考虑艾滋病毒预防干预措施的制定和实施。研究结果将为科学和政策讨论提供信息,说明采取干预措施减少急性期传播的重要性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Steven D. Pinkerton其他文献
Hispanic Adults' Beliefs, Attitudes, and Intentions Regarding the Female Condom
- DOI:
10.1023/a:1005417318841 - 发表时间:
2000-04-01 - 期刊:
- 影响因子:2.900
- 作者:
Laura M. Bogart;Heather Cecil;Steven D. Pinkerton - 通讯作者:
Steven D. Pinkerton
A Method for Evaluating the Economic Efficiency of HIV Behavioral Risk Reduction Interventions
- DOI:
10.1023/a:1022133716954 - 发表时间:
1998-09-01 - 期刊:
- 影响因子:2.400
- 作者:
Steven D. Pinkerton;David R. Holtgrave - 通讯作者:
David R. Holtgrave
What Is a Condom Worth?
- DOI:
10.1023/a:1025485301438 - 发表时间:
1999-12-01 - 期刊:
- 影响因子:2.400
- 作者:
Steven D. Pinkerton;Paul R. Abramson;David R. Holtgrave - 通讯作者:
David R. Holtgrave
Steven D. Pinkerton的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Steven D. Pinkerton', 18)}}的其他基金
Assessing the Cost-Effectiveness of Interventions Along the HIV Treatment Cascade
评估艾滋病毒治疗级联干预措施的成本效益
- 批准号:
9141458 - 财政年份:2016
- 资助金额:
$ 31.25万 - 项目类别:
Cost-Effectiveness of Preventing Acute-Phase HIV Transmission
预防艾滋病毒急性期传播的成本效益
- 批准号:
7230873 - 财政年份:2007
- 资助金额:
$ 31.25万 - 项目类别:
Simulation Tool for HIV/STD Cost-Effectiveness Analysis
HIV/STD 成本效益分析模拟工具
- 批准号:
7092208 - 财政年份:2004
- 资助金额:
$ 31.25万 - 项目类别:
Simulation Tool for HIV/STD Cost-Effectiveness Analysis
HIV/STD 成本效益分析模拟工具
- 批准号:
6894291 - 财政年份:2004
- 资助金额:
$ 31.25万 - 项目类别:
Simulation Tool for HIV/STD Cost-Effectiveness Analysis
HIV/STD 成本效益分析模拟工具
- 批准号:
6843061 - 财政年份:2004
- 资助金额:
$ 31.25万 - 项目类别:
HIV/STD PREVENTION COST-EFFECTIVENESS: METHODS & APPLICS
HIV/性病预防成本效益:方法
- 批准号:
6618133 - 财政年份:2000
- 资助金额:
$ 31.25万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 31.25万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 31.25万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 31.25万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 31.25万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 31.25万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 31.25万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 31.25万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 31.25万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 31.25万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 31.25万 - 项目类别:
Standard Grant